1. Structural and symptomatic benefit of a half-live extended, systemically applied anti-ADAMTS-5 inhibitor (M6495). (April 2018) Authors: Brenneis, C.; Serruys, B.; Van Belle, T.; Poelmans, S.; Kleinschmidt-Doerr, K.; Guehring, H.; Michaelis, M.; Lindemann, S. Journal: Osteoarthritis and cartilage Issue: Volume 26(2018)Supplement 1 Page Start: S299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗